Related Experiment Video
Updated: May 3, 2026
08:26
Development and Validation of an Ultrasensitive Single Molecule Array Digital Enzyme-linked Immunosorbent Assay for Human Interferon-α
Published on: June 14, 2018
11.9K
Measuring interferon alpha and other cytokines in SLE
Mikhail Olferiev1, Mari Lliguicota, Kyriakos A Kirou
1Division of Rheumatology, Hospital for Special Surgery, New York, NY, USA.
Methods in Molecular Biology (Clifton, N.J.)
|February 6, 2014
Summary
Systemic lupus erythematosus (SLE) disease progression involves cytokines. A new assay measures type I interferon (IFN) activity in SLE plasma and peripheral blood cell responses, aiding in understanding disease pathogenesis.
Area of Science:
- Immunology
- Rheumatology
- Molecular Biology
Background:
- Cytokines, including type I interferons (IFN), play a crucial role in the pathogenesis and disease progression of systemic lupus erythematosus (SLE).
- Understanding the functional activity of type I IFN and cellular responses is vital for managing SLE.
- Current methods may not fully capture the dynamic interplay of cytokines in SLE patients.
Purpose of the Study:
- To develop and describe a functional assay for measuring type I IFN activity in plasma from patients with SLE.
- To assess the response of peripheral blood cells to type I IFN in SLE.
- To establish a scalable method for evaluating cytokine activity and cellular responses in relation to SLE parameters.
Main Methods:
- A novel functional assay was developed to quantify type I IFN activity in SLE patient plasma.
- Peripheral blood cells from SLE patients were analyzed for their response to type I IFN.
- The assay's scalability was assessed for broader application in cytokine analysis.
Main Results:
- The study successfully describes a functional assay to measure type I IFN activity in SLE plasma.
- The response of peripheral blood cells to type I IFN was measured.
- The method demonstrates potential for assessing other cytokine activities and cellular responses relevant to SLE.
Conclusions:
- The developed functional assay provides a valuable tool for assessing type I IFN activity in SLE.
- This assay can be scaled to evaluate other cytokine activities and their impact on cellular responses in SLE.
- This research contributes to a better understanding of SLE pathogenesis and offers potential for improved patient management.
